SCOPUS 정보 검색 플랫폼

Volumn 22, Issue 4, 2012, Pages 630-634

The rapid efficacy of abatacept in a patient with rheumatoid vasculitis

(12) Fujii, Wataru a Kohno, Masataka a Ishino, Hidetaka a Nakabayashi, Amane a Fujioka, Kazuki a Kida, Takashi a Nagahara, Hidetake a Murakami, Ken a Nakamura, Kaoru a Seno, Takahiro a Yamamoto, Aihiro a Kawahito, Yutaka a

a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE (Japan)

Author keywords

Abatacept; Cytotoxic T lymphocyteassociated antigen 4 (CTLA4); Rheumatoid vasculitis

Indexed keywords

ABATACEPT; ACETAMINOSALOL; ADALIMUMAB; AZATHIOPRINE; ETANERCEPT; FEXOFENADINE; GLUCOCORTICOID; GRANISETRON; INFLIXIMAB; LOXOPROFEN; METHOTREXATE; METOCLOPRAMIDE; PREDNISOLONE; TACROLIMUS; TOCILIZUMAB;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ACTIVITY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN TISSUE; LABORATORY TEST; LEUKOPENIA; NAUSEA; PERIODONTAL ABSCESS; PLASMAPHERESIS; PRIORITY JOURNAL; RASH; RHEUMATOID ARTHRITIS; RHEUMATOID VASCULITIS; SKIN BIOPSY; THROMBOCYTOPENIA; TREATMENT RESPONSE; VOMITING;

ADULT; ANTIRHEUMATIC AGENTS; DRUG SUBSTITUTION; FEMALE; GLUCOCORTICOIDS; HEALTH STATUS; HUMANS; IMMUNOCONJUGATES; METHOTREXATE; PLASMAPHERESIS; REMISSION INDUCTION; RHEUMATOID VASCULITIS; SEVERITY OF ILLNESS INDEX; TREATMENT FAILURE; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84865375181 PISSN: 14397595 EISSN: 14397609 Source Type: Journal
DOI: 10.1007/s10165-011-0559-8 Document Type: Article

Times cited : (16)

References (26)

1
- 0021339733
- Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis
- DOI 10.1016/0002-9343(84)90654-5
- Scott DG, Bacon PA. Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis. Am J Med. 1984;76:377-84. (Pubitemid 14159547)
- (1984) American Journal of Medicine , vol.76 , Issue.3 , pp. 377-384
- Scott, D.G.I.¹ Bacon, P.A.²

2
- 0030832498
- Vasculitis associated with connective tissue disease
- DOI 10.1016/S0950-3579(97)80048-9
- Breedveld FC. Vasculitis associated with connective tissue disease. Baillieres Clin Rheumatol. 1997;11:315-34. (Pubitemid 27296600)
- (1997) Bailliere's Clinical Rheumatology , vol.11 , Issue.2 , pp. 315-334
- Breedveld, F.C.¹

3
- 0018888663
- Rheumatoid vasculitis: Effect of cyclophosphamide on the clinical course and levels of circulating immune complexes
- Abel T, Andrews BS, Cunningham PH, Brunner CM, Davis JS, Horwitz DA, et al. Rheumatoid vasculitis: effect of cyclophosphamide on the clinical course and levels of circulating immune complexes. Ann Intern Med. 1980;93:407-13. (Pubitemid 10055898)
- (1980) Annals of Internal Medicine , vol.93 , Issue.3 , pp. 407-413
- Abel, T.¹ Andrews, B.S.² Cunningham, P.H.³

4
- 0037809587
- Successful treatment of severe rheumatoid vasculitis by infliximab [1]
- DOI 10.1136/ard.62.6.587
- Unger L, Kayser M, Nüsslein HG. Successful treatment of severe rheumatoid vasculitis by infliximab.AnnRheumDis. 2003;62:587-8. (Pubitemid 36606297)
- (2003) Annals of the Rheumatic Diseases , vol.62 , Issue.6 , pp. 587-588
- Unger, L.¹ Kayser, M.² Nusslein, H.G.³

5
- 23444455315
- Rheumatoid vasculitis treated with infliximab
- van der Bijl AE, Allaart CF, Van Vugt J, Van Duinen S, Breedveld FC. Rheumatoid vasculitis treated with infliximab. J Rheumatol. 2005;32:1607-9. (Pubitemid 41113987)
- (2005) Journal of Rheumatology , vol.32 , Issue.8 , pp. 1607-1609
- Van Der Bijl, A.E.¹ Allaart, C.F.² Van Vugt, J.P.P.³ Van Duinen, S.G.⁴ Breedveld, F.C.⁵

6
- 32144438288
- Should antitumor necrosis factor-alpha be the first therapy for rheumatoid vasculitis?
- Garcia-Porrua C, Gonzalez-Gay MA, Quevedo V. Should antitumor necrosis factor-alpha be the first therapy for rheumatoid vasculitis? J Rheumatol. 2006;33:433-4.
- (2006) J Rheumatol , vol.33 , pp. 433-434
- Garcia-Porrua, C.¹ Gonzalez-Gay, M.A.² Quevedo, V.³

7
- 47949111861
- Abatacept inhibits progression of structural damage in rheumatoid arthritis: Result from the long-term extension of the aim trial
- Genant HK, Peterfy CG, Westhovens R, Becker JC, Aranda R, Vratsanos G, et al. Abatacept inhibits progression of structural damage in rheumatoid arthritis: result from the long-term extension of the AIM trial. Ann Rheum Dis. 2008;67:1084-9.
- (2008) Ann Rheum Dis , vol.67 , pp. 1084-1089
- Genant, H.K.¹ Peterfy, C.G.² Westhovens, R.³ Becker, J.C.⁴ Aranda, R.⁵ Vratsanos, G.⁶

8
- 0023945481
- The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
- Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315-24. (Pubitemid 18091653)
- (1988) Arthritis and Rheumatism , vol.31 , Issue.3 , pp. 315-324
- Arnett, F.C.¹ Edworthy, S.M.² Bloch, D.A.³ McShane, D.J.⁴ Fries, J.F.⁵ Cooper, N.S.⁶ Healey, L.A.⁷ Kaplan, S.R.⁸ Liang, M.H.⁹ Luthra, H.S.¹⁰ Medsger Jr., T.A.¹¹ Mitchell, D.M.¹² Neustadt, D.H.¹³ Pinals, R.S.¹⁴ Schaller, J.G.¹⁵ Sharp, J.T.¹⁶ Wilder, R.L.¹⁷ Hunder, G.G.¹⁸

9
- 72649098710
- Therapeutic criteria in rheumatoid arthritis
- Steinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. J Am Med Assoc. 1949;140:659-62.
- (1949) J Am Med Assoc , vol.140 , pp. 659-662
- Steinbrocker, O.¹ Traeger, C.H.² Batterman, R.C.³

10
- 0040805208
- Arteritis in rheumatoid arthritis
- Schmid FR, Cooper NS, Ziff M, McEwen C. Arteritis in rheumatoid arthritis. Am J Med. 1961;30:56-83.
- (1961) Am J Med , vol.30 , pp. 56-83
- Schmid, F.R.¹ Cooper, N.S.² Ziff, M.³ McEwen, C.⁴

11
- 1842607230
- Epidemiology of extra-articular manifestations in rheumatoid arthritis
- DOI 10.1080/03009740310004621
- Turesson C, Jacobsson LT. Epidemiology of extra-articular manifestations in rheumatoid arthritis. Scand J Rheumatol. 2004; 33:65-72. (Pubitemid 38437967)
- (2004) Scandinavian Journal of Rheumatology , vol.33 , Issue.2 , pp. 65-72
- Turesson, C.¹ Jacobsson, L.T.H.²

12
- 33749130632
- Systemic rheumatoid vasculitis: A review
- DOI 10.1016/j.semarthrit.2006.04.006, PII S0049017206000631
- Genta MS, Genta RM, Gabay C. Systemic rheumatoid vasculitis: a review. Semin Arthritis Rheum. 2006;36:88-98. (Pubitemid 44470788)
- (2006) Seminars in Arthritis and Rheumatism , vol.36 , Issue.2 , pp. 88-98
- Genta, M.S.¹ Genta, R.M.² Gabay, C.³

13
- 0025155123
- Vasculitis associated with rheumatoid arthritis
- Vollertsen RS, Conn DL. Vasculitis associated with rheumatoid arthritis. Rheum Dis Clin North Am. 1990;16:445-61. (Pubitemid 20380161)
- (1990) Rheumatic Disease Clinics of North America , vol.16 , Issue.2 , pp. 445-461
- Vollertsen, R.S.¹ Conn, D.L.²

14
- 0019440673
- Systemic rheumatoid vasculitis: A clinical and laboratory study of 50 cases
- Scott DG, Bacon PA, Tribe CR. Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases. Medicine (Baltimore). 1981;60:288-97. (Pubitemid 11079845)
- (1981) Medicine , vol.60 , Issue.4 , pp. 288-297
- Scott, D.G.I.¹ Bacon, P.A.² Tribe, C.R.³

15
- 79960403316
- Cytotoxic t-lymphocyte-associated antigen-4
- Salama AK, Hodi FS. Cytotoxic T-lymphocyte-associated antigen-4. Clin Cancer Res. 2011;17:4622-8.
- (2011) Clin Cancer Res , vol.17 , pp. 4622-4628
- Salama, A.K.¹ Hodi, F.S.²

16
- 54549119268
- Co-stimulatory modulation in rheumatoid arthritis: The role of (ctla4-ig) abatacept
- Fiocco U, Sfriso P, Oliviero F, Pagnin E, Scagliori E, Campana C, et al. Co-stimulatory modulation in rheumatoid arthritis: the role of (CTLA4-Ig) abatacept. Autoimmun Rev. 2008;8:76-82.
- (2008) Autoimmun Rev , vol.8 , pp. 76-82
- Fiocco, U.¹ Sfriso, P.² Oliviero, F.³ Pagnin, E.⁴ Scagliori, E.⁵ Campana, C.⁶

17
- 0035927054
- Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis
- DOI 10.1084/jem.193.10.1159
- Yen JH, Moore BE, Nakajima T, Scholl D, Schaid DJ, Weyand CM, et al. Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis. J Exp Med. 2001;193:1159-67. (Pubitemid 32488368)
- (2001) Journal of Experimental Medicine , vol.193 , Issue.10 , pp. 1159-1167
- Yen, J.-H.¹ Moore, B.E.² Nakajima, T.³ Scholl, D.⁴ Schaid, D.J.⁵ Weyand, C.M.⁶ Goronzy, J.J.⁷

18
- 0032907826
- Cytokine profiles in Wegener's granulomatosis: Predominance of type 1 (Th1) in the granulomatous inflammation
- DOI 10.1002/1529-0131(199904)42:4<742::AID-ANR18>3.0.CO;2-I
- Csernok E, Trabandt A, Müller A, Wang GC, Moosig F, Paulsen J, et al. Cytokine profiles in Wegener's granulomatosis: predominance of type 1 (Th1) in the granulomatous inflammation. Arthritis Rheum. 1999;42:742-50. (Pubitemid 29171995)
- (1999) Arthritis and Rheumatism , vol.42 , Issue.4 , pp. 742-750
- Csernok, E.¹ Trabandt, A.² Muller, A.³ Wang, G.C.⁴ Moosig, F.⁵ Paulsen, J.⁶ Schnabel, A.⁷ Gross, W.L.⁸

19
- 79960435747
- Both th2 and th17 responses are involved in the pathogenesis of churg-strauss syndrome
- Jakiela B, Sanak M, Szczeklik W, Sokolowska B, Plutecka H, Mastalerz L, et al. Both Th2 and Th17 responses are involved in the pathogenesis of Churg-Strauss syndrome. Clin Exp Rheumatol. 2011;29:S23-34.
- (2011) Clin Exp Rheumatol , vol.29
- Jakiela, B.¹ Sanak, M.² Szczeklik, W.³ Sokolowska, B.⁴ Plutecka, H.⁵ Mastalerz, L.⁶

20
- 53749094183
- Ctla-4 control over foxp3? Regulatory t cell function
- Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T, Miyara M, Fehervari Z, et al. CTLA-4 control over Foxp3? regulatory T cell function. Science. 2008;322:271-5.
- (2008) Science , vol.322 , pp. 271-275
- Wing, K.¹ Onishi, Y.² Prieto-Martin, P.³ Yamaguchi, T.⁴ Miyara, M.⁵ Fehervari, Z.⁶

21
- 73149083260
- Confirmation of the genetic association of ctla4 and ptpn22 with anca-associated vasculitis
- Carr EJ, Niederer HA, Williams J, Harper L, Watts RA, Lyons PA, et al. Confirmation of the genetic association of CTLA4 and PTPN22 with ANCA-associated vasculitis. BMC Med Genet. 2009;10:121.
- (2009) BMC Med Genet , vol.10 , pp. 121
- Carr, E.J.¹ Niederer, H.A.² Williams, J.³ Harper, L.⁴ Watts, R.A.⁵ Lyons, P.A.⁶

22
- 4043093546
- An analysis of CTLA-4 and proinflammatory cytokine genes in Wegener's granulomatosis
- DOI 10.1002/art.20385
- Zhou Y, Huang D, Paris PL, Sauter CS, Prock KA, Hoffman GS. An analysis of CTLA-4 and proinflammatory cytokine genes in Wegener's granulomatosis. Arthritis Rheum. 2004;50:2645-50. (Pubitemid 39062727)
- (2004) Arthritis and Rheumatism , vol.50 , Issue.8 , pp. 2645-2650
- Zhou, Y.¹ Huang, D.² Paris, P.L.³ Sauter, C.S.⁴ Prock, K.A.⁵ Hoffman, G.S.⁶

23
- 77954651554
- Rituximab versus cyclophosphamide for anca-associated vasculitis
- Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010;363:221-32.
- (2010) N Engl J Med , vol.363 , pp. 221-232
- Stone, J.H.¹ Merkel, P.A.² Spiera, R.³ Seo, P.⁴ Langford, C.A.⁵ Hoffman, G.S.⁶

24
- 33750222100
- Successful treatment of rheumatoid vasculitis-associated foot drop with rituximab [7]
- DOI 10.1093/rheumatology/kel318
- Maher LV, Wilson JG. Successful treatment of rheumatoid vasculitis-associated foot drop with rituximab. Rheumatology (Oxford). 2006;45:1450-1. (Pubitemid 44605489)
- (2006) Rheumatology , vol.45 , Issue.11 , pp. 1450-1451
- Maher, L.M.¹ Wilson, J.G.²

25
- 44849126368
- Successful treatment of rheumatoid vasculitis-associated cutaneous ulcers using rituximab in two patients with rheumatoid arthritis
- DOI 10.1093/rheumatology/ken129
- Hellmann M, Jung N, Owczarczyk K, Hallek M, Rubbert A. Successful treatment of rheumatoid vasculitis-associated cutaneous ulcers using rituximab in two patients with rheumatoid arthritis. Rheumatology (Oxford). 2008;47:929-30. (Pubitemid 351796389)
- (2008) Rheumatology , vol.47 , Issue.6 , pp. 929-930
- Hellmann, M.¹ Jung, N.² Owczarczyk, K.³ Hallek, M.⁴ Rubbert, A.⁵

26
- 66149093043
- Safety and efficacy of the selective costimulation modulator abatacept in patients with rheumatoid arthritis receiving background methotrexate: A 5-year extended phase iib study
- Westhovems R, Kremer JM, Moreland LW, Emery P, Russell AS, Li T, et al. Safety and efficacy of the selective costimulation modulator abatacept in patients with rheumatoid arthritis receiving background methotrexate: a 5-year extended phase IIB study. J Rheumatol. 2009;36:736-42
- (2009) J Rheumatol , vol.36 , pp. 736-742
- Westhovems, R.¹ Kremer, J.M.² Moreland, L.W.³ Emery, P.⁴ Russell, A.S.⁵ Li, T.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.